Patrick G. Enright, Director at Jazz Pharmaceuticals plc (JAZZ), sold 702 shares at $148.40 ($104K) on 2017-08-25, disclosed to the SEC on 2017-08-28.
Seasonal sale ($104k) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $148.40 | 351 | $52K | 50.0% |
| 2 | $148.40 | 351 | $52K | 50.0% |
| Total | $148.40 avg | 702 | $104K | 100% |
| Filing → |
| ZBIO | BUY | 2025-10-14 | $2.5M | — | Filing → |
| VERA | BUY | 2025-06-25 | $10.6M | — | Filing → |
| BIOA | BUY | 2024-09-27 | $7.2M | — | Filing → |